» Articles » PMID: 18813320

Basal Cell Carcinomas: Attack of the Hedgehog

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2008 Sep 25
PMID 18813320
Citations 322
Authors
Affiliations
Soon will be listed here.
Abstract

Basal cell carcinomas (BCCs) were essentially a molecular 'black box' until some 12 years ago, when identification of a genetic flaw in a rare subset of patients who have a great propensity to develop BCCs pointed to aberrant Hedgehog signalling as the pivotal defect leading to formation of these tumours. This discovery has facilitated a remarkable increase in our understanding of BCC carcinogenesis and has highlighted the carcinogenic role of this developmental pathway when aberrantly activated in adulthood. Importantly, a phase 1 first-in-human trial of a Hedgehog inhibitor has shown real progress in halting and even reversing the growth of these tumours.

Citing Articles

Ocular comorbidities in basal cell carcinoma: a national cross-sectional analysis.

Kooner A, Sekhon R, Gill M Arch Dermatol Res. 2025; 317(1):455.

PMID: 39987254 DOI: 10.1007/s00403-025-03984-8.


Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.

Martins M, Veiga F, Paiva-Santos A, Pires P ACS Pharmacol Transl Sci. 2025; 8(2):308-338.

PMID: 39974652 PMC: 11833728. DOI: 10.1021/acsptsci.4c00679.


Case report: Basal cell carcinoma arising within the nevus sebaceous: report of 4 cases and literature review.

Lei T, Lu Y, Feng Y, Ni Y Front Oncol. 2025; 14():1478747.

PMID: 39839803 PMC: 11746038. DOI: 10.3389/fonc.2024.1478747.


Proximity based proteomics reveals Git1 as a regulator of Smoothened signaling.

Zhang J, Kaur G, Cai E, Gutierrez O, Liu X, Baboo S bioRxiv. 2025; .

PMID: 39829937 PMC: 11741329. DOI: 10.1101/2025.01.06.631593.


The thyroid hormone activating enzyme, DIO2, is a potential pan-cancer biomarker and immunotherapy target.

Nappi A, Miro C, Cicatiello A, Sagliocchi S, Acampora L, Restolfer F J Endocrinol Invest. 2025; .

PMID: 39821172 DOI: 10.1007/s40618-024-02526-9.


References
1.
Yu M, Zloty D, Cowan B, Shapiro J, Haegert A, Bell R . Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J Invest Dermatol. 2008; 128(7):1797-805. DOI: 10.1038/sj.jid.5701243. View

2.
Kricker A, Armstrong B, English D, Heenan P . Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer. 1995; 60(4):489-94. DOI: 10.1002/ijc.2910600411. View

3.
Evans D, Farndon P, Burnell L, Gattamaneni H, Birch J . The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer. 1991; 64(5):959-61. PMC: 1977448. DOI: 10.1038/bjc.1991.435. View

4.
Neill G, Harrison W, Ikram M, Williams T, Bianchi L, Nadendla S . GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes. Carcinogenesis. 2008; 29(4):738-46. DOI: 10.1093/carcin/bgn037. View

5.
Kim I, Ackerson T, Ramakrishna S, Tretiakova M, Wang I, Kalin T . The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res. 2006; 66(4):2153-61. DOI: 10.1158/0008-5472.CAN-05-3003. View